F8V3I9 (F8V3I9_FELCA) Felis catus (Cat) (Felis silvestris catus)

Elongin-C UniProtKBInterProSTRINGInteractive Modelling

112 aa; Sequence (Fasta) 128 identical sequences

Sequence Features

Add
 18-80SKP1 component, POZ domain
IPR016073PF03931

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; 		6r7h1-112
Assess
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P40337; P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; 		6r7f1-112
Assess
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
P40337; Q15369; Q15370; Q99814; 		1×FMT;6i7r16-112
Assess
von Hippel-Lindau protein-ElonginB-ElonginC complex, bound to Hif1- alpha peptide Heteromer
P40337; Q15369; Q15370; Q16665; 		1×GOL;4ajy17-112
Assess
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
P40337; Q15369; Q15370; Q16665; 		1×SO4; 1×F4K; 1×GOL;6gmr17-112
Assess
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:El… Heteromer
P40337; P51532; Q15369; Q15370; 		1×FWZ; 1×DMS;6hr217-112
Assess
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
P40337; Q15370; Q2KII4; Q99814; 		1×GOL;6i7q17-112
Assess
Crystal structure of a B30.2/SPRY domain-containing protein GUSTAVUS in complex with Elongin B and … Heteromer
A1Z6E0; P62869; P83940; 		2fnj17-112
Assess
pVHL:EloB:EloC in complex with modified HIF-1a CODD peptide containing (3R,4S)-3-fluoro-4-hydroxypr… Heteromer
P40337; Q15369; Q15370; Q16665; 		6gfx17-112
Assess
Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex Heteromer
P40337; Q15369; Q15370; Q16665; 		1lm817-112
Assess
CRYSTAL STRUCTURE OF SOCS-2 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 1.9A RESOLUTION Heteromer
O14508; Q15369; Q15370; 		3×SO4; 3×NI;2c9w17-112
Assess
PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL Heteromer
P40337; Q07817; Q15369; Q15370; 		1×QL8; 17×EDO; 9×GOL; 12×IOD;6zhc17-112
Assess
pVHL:EloB:EloC in complex with methyl 4H-furo[3,2-b]pyrrole-5-carboxylate Heteromer
P40337; Q15369; Q15370; 		2×ACT; 1×F4E;6gmn17-112
Assess
Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide Heteromer
O14508; Q15369; Q15370; 		1×CO;6i5n17-112
Assess
pVHL-ELOB-ELOC complex_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)ben… Heteromer
P40337; Q15369; Q15370; 		1×TG0;4b9k17-112
Assess
Crystal structure of a hydroxylated HIF-1 alpha peptide bound to the pVHL/elongin-C/elongin-B compl… Heteromer
P40337; Q15369; Q15370; Q16665; 		1×SO4;1lqb17-112
Assess
Crystal structure of HIF-2alpha-pVHL-elongin B-elongin C Heteromer
P40337; Q15369; Q15370; Q99814; 		6bvb17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-4-hydroxy-1-((S)-2-(2-hydroxyacetamido)-3,3-dimethylbutanoyl… Heteromer
P40337; Q15369; Q15370; 		1×9BT;5nvv17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-y… Heteromer
P40337; Q15369; Q15370; 		1×3JU;4w9f17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-3,3-dimethylb… Heteromer
P40337; Q15369; Q15370; 		1×3JO;4w9k17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hy… Heteromer
P40337; Q15369; Q15370; 		1×9BH;5nw117-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamido-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-m… Heteromer
P40337; Q15369; Q15370; 		1×3JF;4w9h17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(oxazol-5-yl)benzyl)… Heteromer
P40337; Q15369; Q15370; 		1×3JG;4w9c17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methyloxazol-5-yl… Heteromer
P40337; Q15369; Q15370; 		1×3JK;4w9d17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3,3-dimethylbutanamido)-3,3-dimeth… Heteromer
P40337; Q15369; Q15370; 		1×3JJ;4w9l17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-3,3-dimethylb… Heteromer
P40337; Q15369; Q15370; 		1×3JH;4w9j17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-fluorocyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
P40337; Q15369; Q15370; 		1×4YY;5nvx17-112
Assess
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-… Heteromer
P40337; Q15369; Q15370; 		1×X6C; 1×ACT;4bks17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-h… Heteromer
P40337; Q15369; Q15370; 		1×9BW;5nvw17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-3,3-dimethyl-2-(oxetane-3-carboxamido)butanoyl)-4-hyd… Heteromer
P40337; Q15369; Q15370; 		1×9B8;5nw217-112
Assess
Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370; 		1×FX8; 11×EDO; 1×FMT;6hay17-112
Assess
Ternary complex of VHL/BRD4-BD1/Compound9 (4-(3,5-difluoropyridin-2-yl)-N-(11-(((S)-1-((2S,4R)-4-hy… Heteromer
O60885; P40337; Q15369; Q15370; 		1×WEP;7khh17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetamidocyclopropanecarboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370; 		1×9BK;5nw017-112
Assess
pVHL:EloB:EloC in complex with modified VH032 containing (3S,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
P40337; Q15369; Q15370; 		1×EXE;6gfz17-112
Assess
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methy… Heteromer
P40337; Q15369; Q15370; 		1×QD0;4bkt17-112
Assess
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370; 		8×EDO; 1×FWZ; 1×EPE;6hax17-112
Assess
Crystal Structure of the HIV Vif BC-box in Complex with Human ElonginB and ElonginC Heteromer
P12504; Q15369; Q15370; 		3dcg17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carbonyl)-4-hydro… Heteromer
P40337; Q15369; Q15370; 		1×3JS;4w9i17-112
Assess
pVHL:EloB:EloC in complex with VH298 Heteromer
P40337; Q15369; Q15370; 		1×6Z3;5lli17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthi… Heteromer
P40337; Q15369; Q15370; 		1×DV5;6fmj17-112
Assess
pVHL:EloB:EloC complex, in complex with capped Hydroxyproline Heteromer
P40337; Q15369; Q15370; 		3×ACT; 1×V6F;4awj17-112
Assess
pVHL54-213-EloB-EloC complex_(2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol- 5-yl)acetyl)-N-(4-nitrobenzy… Heteromer
P40337; Q15369; Q15370; 		1×GOL; 1×ZUN;3zun17-112
Assess
pVHL:EloB:EloC in complex with 6-chlorothiochroman-4-one Heteromer
P40337; Q15369; Q15370; 		1×F7B; 1×IPA;6gmx17-112
Assess
CRYSTAL STRUCTURE OF SOCS-4 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 2.55A RESOLUTION Heteromer
Q15369; Q15370; Q8WXH5; 		1×NA; 1×EDO; 1×CL;2izv17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(thiazol-5-yl)benzyl… Heteromer
P40337; Q15369; Q15370; 		1×3JT;4w9e17-112
Assess
pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisox… Heteromer
P40337; Q15369; Q15370; 		1×TR0;3ztc17-112
Assess
Crystal structure of SOCS2:Elongin C:Elongin B in complex with erythropoietin receptor peptide Heteromer
O14508; Q15369; Q15370; 		1×PEG;6i4x17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(3-methyl-4-(thiazol-5-… Heteromer
P40337; Q15369; Q15370; 		1×3JV;4w9g17-112
Assess
The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB Heteromer
O60885; P40337; Q15369; Q15370; 		1×759;5t3517-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
P40337; Q15369; Q15370; 		1×9BN;5nvz17-112
Assess
THE VHL-ELONGINC-ELONGINB STRUCTURE Heteromer
P40337; Q15369; Q15370; 		1vcb17-112
Assess
pVHL:EloB:EloC in complex with modified VH032 containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
P40337; Q15369; Q15370; 		1×EXH;6gfy17-112
Assess
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
P40337; Q15369; Q15370; 		1×DV8;6fmk17-112
Assess
pVHL54-213-EloB-EloC complex _ methyl 4-(((2S,4R)-4-hydroxy-1-(2-(3- methylisoxazol-5-yl)acetyl)pyr… Heteromer
P40337; Q15369; Q15370; 		1×ZTD;3ztd17-112
Assess
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
P40337; Q15369; Q15370; 		1×DV2;6fmi17-112
Assess
pVHL54-213-EloB-EloC complex_apo Heteromer
P40337; Q15369; Q15370; 		3zrf17-112
Assess
Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide Heteromer
O14508; Q15369; Q15370; 		1×CO;6i5j17-112
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamidopropanoyl)-4-hydroxy-N-(4-(4-methylthiazol… Heteromer
P40337; Q15369; Q15370; 		1×9B5;5nvy17-112
Assess
pVHL54-213-EloB-EloC complex (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL… Heteromer
P40337; Q15369; Q15370; 		1×L8B;3zrc17-112
Assess
Structure of SOCS2:Elongin C:Elongin B from DMSO-treated crystals Heteromer
O14508; Q15369; Q15370; 		5bo417-112
Assess
Crystal structure of SIVrcm Vif-CBFbeta-ELOB-ELOC complex Heteromer
E1ANT9; Q13951; Q15369; Q15370; 		1×ZN; 1×GOL;6p5917-112
Assess
Structure of the SOCS2-Elongin BC complex bound to an N-terminal fragment of Cullin5 Heteromer
O14508; P62869; P83940; Q93034; 		4jgh17-112
Assess
Crystal Structure of SOCS1 in complex with ElonginB and ElonginC Heteromer
C0LEJ4; Q00560; Q15369; Q15370; 		6c5x17-112
Assess
Structure of VHL-EloB-EloC-Cul2 Heteromer
P40337; Q13617; Q15369; Q15370; 		4wqo17-112
Assess
Crystal structure of macrocyclic PROTAC 1 in complex with the second bromodomain of human Brd4 and … Heteromer
O60885; P40337; Q15369; Q15370; 		1×LFE;6sis17-112
Assess
Crystal structure of the Cul2-Rbx1-EloBC-VHL ubiquitin ligase complex Heteromer
P40337; P62877; Q13617; Q15369; Q15370; 		3×ZN;5n4w17-112
Assess
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; 		3×ZN;6r7n17-112
Assess
SOCS box elonginBC ternary complex Heteromer
O35718; P83940; Q15370; 		2jz317-112
Assess
Crystal Structure of Ankyrin Repeat and Socs Box-Containing Protein 9 (Asb9) in Complex with Elongi… Heteromer
Q15369; Q15370; Q96DX5; 		1×EDO; 1×PEG; 1×CL;3zkj18-112
Assess
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
P40337; Q15369; Q15370; 		6gmq17-111
Assess
pVHL-EloB-EloB-EloC complex_(2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidany… Heteromer
P40337; Q15369; Q15370; 		1×ACT; 1×UCK;4b9518-112
Assess
Ankyrin repeat and SOCS-box protein 9 (ASB9) in complex with ElonginB and ElonginC Heteromer
Q15369; Q15370; Q96DX5; 		1×EDO;3zng18-112
Assess
Crystal structure of the Vif-CBFbeta-CUL5-ElOB-ElOC pentameric complex Heteromer
P12504; Q13951; Q15369; Q15370; Q93034; 		1×ZN;4n9f17-111
Assess
Ankyrin repeat and SOCS-box protein 9 (ASB9), ElonginB (ELOB), and ElonginC (ELOC) bound to its sub… Heteromer
P12277; Q15369; Q15370; Q96DX5; 		6v9h18-112
Assess
HIV-1 Vif SOCS-box and Elongin BC solution structure Heteromer
P12504; Q15369; Q15370; 		2ma919-109
Assess